Written Question · S1W-24065 · Session 1
Further to the answer to question S1W-23111 by Malcolm Chisholm on 7 March 2002, whether there are any plans to ensure that the single meas…
The question
To ask the Scottish Executive, further to the answer to question S1W-23111 by Malcolm Chisholm on 7 March 2002, whether there are any plans to ensure that the single measles vaccine is assessed by the UK Licensing Authority against the criteria of safety, quality and efficiency.
The answer
A full and formal assessment of product safety, quality and efficacy occurs in response to an application, by a pharmaceutical company, to the UK licensing authority for a marketing authorisation (product license). Marketing authorisations (product licenses) have been granted for single measles vaccine and these licenses are extant. The Medicines Control Agency is given more basic information about plans to import unlicensed medicinal products, such as unlicensed single measles vaccine. That notification is the subject of professional negative vetting for any evidence of quality or safety issues and whether there are any licensed equivalent products available on the market in the UK. The agency may object to importation if negative vetting raises any concerns.
In the Official Report
No contribution in the Official Report cites S1W-24065 by reference.